Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 Görünümler
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Daha fazla göster
Facebook Yorumları
Hiçbir yorum bulunamadı